Encompass Health Long Term Debt 2010-2023 | EHC

Encompass Health long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • Encompass Health long term debt for the quarter ending December 31, 2023 was $2.688B, a 1.97% decline year-over-year.
  • Encompass Health long term debt for 2023 was $2.688B, a 1.97% decline from 2022.
  • Encompass Health long term debt for 2022 was $2.742B, a 15.39% decline from 2021.
  • Encompass Health long term debt for 2021 was $3.241B, a 0.31% decline from 2020.
Encompass Health Annual Long Term Debt
(Millions of US $)
2023 $2,688
2022 $2,742
2021 $3,241
2020 $3,251
2019 $3,023
2018 $2,479
2017 $2,545
2016 $2,979
2015 $3,135
2014 $2,090
2013 $1,505
2012 $1,240
2011 $1,236
2010 $1,497
2009 $1,641
Encompass Health Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $2,688
2023-09-30 $2,693
2023-06-30 $2,698
2023-03-31 $2,723
2022-12-31 $2,742
2022-09-30 $2,719
2022-06-30 $3,234
2022-03-31 $3,221
2021-12-31 $3,241
2021-09-30 $3,142
2021-06-30 $3,106
2021-03-31 $3,160
2020-12-31 $3,251
2020-09-30 $3,539
2020-06-30 $3,547
2020-03-31 $3,322
2019-12-31 $3,023
2019-09-30 $2,962
2019-06-30 $2,720
2019-03-31 $2,522
2018-12-31 $2,479
2018-09-30 $2,504
2018-06-30 $2,601
2018-03-31 $2,544
2017-12-31 $2,545
2017-09-30 $2,591
2017-06-30 $2,625
2017-03-31 $2,916
2016-12-31 $2,979
2016-09-30 $2,974
2016-06-30 $3,050
2016-03-31 $3,080
2015-12-31 $3,135
2015-09-30 $2,801
2015-06-30 $2,104
2015-03-31 $2,123
2014-12-31 $2,090
2014-09-30 $1,441
2014-06-30 $1,475
2014-03-31 $1,503
2013-12-31 $1,505
2013-09-30 $1,306
2013-06-30 $1,320
2013-03-31 $1,365
2012-12-31 $1,240
2012-09-30 $1,242
2012-06-30 $1,219
2012-03-31 $1,246
2011-12-31 $1,236
2011-09-30 $1,309
2011-06-30 $1,440
2011-03-31 $1,551
2010-12-31 $1,497
2010-09-30 $1,639
2010-06-30 $1,633
2010-03-31 $1,636
2009-12-31 $1,641
2009-09-30 $1,675
2009-06-30 $1,680
2009-03-31 $1,706
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.509B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.956B 10.26
Quest Diagnostics (DGX) United States $15.068B 15.57
DaVita (DVA) United States $12.004B 14.91
Chemed (CHE) United States $8.645B 26.80
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.218B 19.75
RadNet (RDNT) United States $3.843B 104.00
Amedisys (AMED) United States $3.017B 21.38
LifeStance Health (LFST) United States $2.641B 0.00
Astrana Health (ASTH) United States $2.147B 26.80
Addus HomeCare (ADUS) United States $1.602B 22.92
U.S Physical Therapy (USPH) United States $1.601B 41.49
Pennant (PNTG) United States $0.647B 34.24
Aveanna Healthcare Holdings (AVAH) United States $0.456B 0.00
Atai Life Sciences (ATAI) Germany $0.355B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.012B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00